Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: Cardiol Clin. 2019 Aug 26;37(4):365–384. doi: 10.1016/j.ccl.2019.07.003

Figure 3.

Figure 3.

Therapeutic intervention to improve vascular health, especially in patients on cancer therapeutics with an inhibitory effect on the VEGF signaling pathway. From Touyz RM, Herrmann SMS, Herrmann J. Vascular toxicities with VEGF inhibitor therapies-focus on hypertension and arterial thrombotic events. J Am Soc Hypertens. 2018;12(6):409–425; with permission.